Advertisement
Advertisement

CLLS

CLLS logo

Cellectis S.A. - ADR

3.50
USD
Sponsored
-0.02
-0.57%
May 22, 16:00 UTC -4
Closed
exchange

After-Market

3.50

0.00
0.00%

Cellectis S.A. - ADR Profile

About

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Info & Links

CEO

Andr� Choulika

Headquarters

8 RUE DE LA CROIX JARRY
PARIS, LLE-DE-FRANCE, I0 75013, FRANCE

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cellectis.com

Auditor

Ernst & Young et Autres

Share holders

--

Employees

229

Cellectis S.A. - ADR Statistics

Valuation Measures

Market Capitalization2

352.14M

Enterprise Value

393.70M

Enterprise Value/EBITDA(ttm)

-16.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.41

Price to Book(mrq)

4.63

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-84.92%

Profit Margin(ttm)

-123.80%

Return on Equity(ttm)

-69.38%

Return on Invested Capital(ttm)

-43.55%

Return on Assets(ttm)

-19.51%

Income Statement

Revenue(ttm)

75.11M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

75.11M

EBITDA(ttm)3

-24.40M

Net Income Available to Common(ttm)

-67.23M

Diluted EPS(ttm)

-0.67

Share Statistics

Beta (5Y Monthly)

2.91

52-Week Change

138.10%

S&P 500 52-Week Change

26.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

83.87M

% Held by Insiders

16.41%

% Held by Institutions

63.90%

Balance Sheet

Total Cash(mrq)

185.66M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

76.40M

Total Debt/Equity(mrq)

111.29%

Current Ratio(mrq)

1.62%

Quick Ratio(mrq)

1.62%

Book Value Per Share(mrq)

1.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.39

Free Cash Flow(ytd)

-41.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement